Onconetix, Inc. (ONCO)
1.62
+0.03
(+1.89%)
USD |
NASDAQ |
Jan 15, 16:00
1.50
-0.12
(-7.41%)
After-Hours: 17:35
Onconetix Profit Margin (Quarterly): -2.89K% for Sept. 30, 2025
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| CEL-SCI Corp. | -- |
| AIM ImmunoTech, Inc. | -12.63K% |
| IGC Pharma, Inc. | -953.4% |
| NovaBay Pharmaceuticals, Inc. | -255.9% |
| Protalix Biotherapeutics, Inc. | 13.19% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -377.2% |
| Return on Assets | -166.1% |
| Return on Invested Capital | -224.6% |
| Gross Profit Margin (Quarterly) | 88.54% |
| Operating Margin (Quarterly) | -681.3% |
| Return on Net Operating Assets | -171.5% |